Search Results
Search for other papers by Lukas Plachy in
Google Scholar
PubMed
Search for other papers by Petra Dusatkova in
Google Scholar
PubMed
Search for other papers by Klara Maratova in
Google Scholar
PubMed
Search for other papers by Shenali Anne Amaratunga in
Google Scholar
PubMed
Search for other papers by Dana Zemkova in
Google Scholar
PubMed
Search for other papers by Vit Neuman in
Google Scholar
PubMed
Search for other papers by Stanislava Kolouskova in
Google Scholar
PubMed
Search for other papers by Barbora Obermannova in
Google Scholar
PubMed
Search for other papers by Marta Snajderova in
Google Scholar
PubMed
Search for other papers by Zdenek Sumnik in
Google Scholar
PubMed
Search for other papers by Jan Lebl in
Google Scholar
PubMed
Search for other papers by Stepanka Pruhova in
Google Scholar
PubMed
Introduction Combined pituitary hormone deficiency (CPHD) is characterized by growth hormone deficiency (GHD) associated with a shortage of at least one other pituitary hormone ( 1 ). The etiology of CPHD is complex, including acquired
Search for other papers by Fernanda A Correa in
Google Scholar
PubMed
Search for other papers by Ericka B Trarbach in
Google Scholar
PubMed
Search for other papers by Cintia Tusset in
Google Scholar
PubMed
Search for other papers by Ana Claudia Latronico in
Google Scholar
PubMed
Search for other papers by Luciana R Montenegro in
Google Scholar
PubMed
Search for other papers by Luciani R Carvalho in
Google Scholar
PubMed
Search for other papers by Marcela M Franca in
Google Scholar
PubMed
Search for other papers by Aline P Otto in
Google Scholar
PubMed
Search for other papers by Everlayny F Costalonga in
Google Scholar
PubMed
Search for other papers by Vinicius N Brito in
Google Scholar
PubMed
Search for other papers by Ana Paula Abreu in
Google Scholar
PubMed
Search for other papers by Mirian Y Nishi in
Google Scholar
PubMed
Search for other papers by Alexander A L Jorge in
Google Scholar
PubMed
Search for other papers by Ivo J P Arnhold in
Google Scholar
PubMed
Search for other papers by Yisrael Sidis in
Google Scholar
PubMed
Search for other papers by Nelly Pitteloud in
Google Scholar
PubMed
Search for other papers by Berenice B Mendonca in
Google Scholar
PubMed
Introduction Combined pituitary hormone deficiencies (CPHD) are defined as the deficiency of two or more pituitary hormones. They can be associated with complex phenotypes such as cranial/facial midline defects and other extra-pituitary features
Search for other papers by Marilena Nakaguma in
Google Scholar
PubMed
Search for other papers by Fernanda A Correa in
Google Scholar
PubMed
Search for other papers by Lucas S Santana in
Google Scholar
PubMed
Search for other papers by Anna F F Benedetti in
Google Scholar
PubMed
Search for other papers by Ricardo V Perez in
Google Scholar
PubMed
Search for other papers by Martha K P Huayllas in
Google Scholar
PubMed
Search for other papers by Mirta B Miras in
Google Scholar
PubMed
Search for other papers by Mariana F A Funari in
Google Scholar
PubMed
Search for other papers by Antonio M Lerario in
Google Scholar
PubMed
Search for other papers by Berenice B Mendonca in
Google Scholar
PubMed
Search for other papers by Luciani R S Carvalho in
Google Scholar
PubMed
Search for other papers by Alexander A L Jorge in
Google Scholar
PubMed
Search for other papers by Ivo J P Arnhold in
Google Scholar
PubMed
deficiency (IGHD) to combined pituitary hormone deficiencies (CPHD). CH also varies with respect to hypothalamic–pituitary anatomy from normal magnetic resonance imaging to the presence of midline defects such as pituitary stalk interruption syndrome (PSIS
Search for other papers by Izabelle Lövgren in
Google Scholar
PubMed
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK
Search for other papers by Azadeh Abravan in
Google Scholar
PubMed
Search for other papers by Abigail Bryce-Atkinson in
Google Scholar
PubMed
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK
Search for other papers by Marcel van Herk in
Google Scholar
PubMed
. Damage to important brain regions, such as the hypothalamus and pituitary gland, can lead to detrimental secondary effects such as hormone deficiency, which can further deteriorate the patient’s overall health ( 8 ). Figure 1 The intended effect of
Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Search for other papers by Ken K Y Ho in
Google Scholar
PubMed
Search for other papers by Bradley S Miller in
Google Scholar
PubMed
Search for other papers by Ignacio Bergada in
Google Scholar
PubMed
Search for other papers by Alan D Rogol in
Google Scholar
PubMed
Introduction Growth hormone deficiency (GHD) is a clinical syndrome that can present either as isolated GHD or associated with additional pituitary hormone deficiencies in children and adults. Childhood-onset GHD (CO-GHD) is often idiopathic
Search for other papers by Caiyan Mo in
Google Scholar
PubMed
Search for other papers by Tao Tong in
Google Scholar
PubMed
Search for other papers by Ying Guo in
Google Scholar
PubMed
Search for other papers by Zheng Li in
Google Scholar
PubMed
Search for other papers by Liyong Zhong in
Google Scholar
PubMed
Introduction Growth hormone-secreting pituitary adenoma (GHPA) is due to the overproduction of growth hormone (GH) by pituitary adenomas, which stimulates the liver to produce insulin-like growth factor 1 (IGF-1), and the long
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
Search for other papers by Biagio Cangiano in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
Search for other papers by Marco Bonomi in
Google Scholar
PubMed
Pfäffle R Klammt J . Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency . Best Practice and Research. Clinical Endocrinology and Metabolism 2011 25 43 – 60 . ( https://doi.org/10.1016/j.beem.2010.10.014 ) 10
Search for other papers by Stefan M Constantinescu in
Google Scholar
PubMed
Search for other papers by Thierry Duprez in
Google Scholar
PubMed
Search for other papers by Edward Fomekong in
Google Scholar
PubMed
Search for other papers by Christian Raftopoulos in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
was present. Weakness was considered as potentially due to NFPMA in case of any pituitary hormone deficiency. Endocrinological and ophthalmological evaluation We evaluated endocrine status by serum levels of pituitary hormones with no
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Nathalie Ly in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Sophie Dubreuil in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Sorbonne University, Paris, France
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
defined as an insufficient GH peak during insulin tolerance test (ITT) (severe GHD if GH peak < 10 mU/L; partial GHD if GH peak between 10 and 20 mU/L). According to 2007 consensus guidelines, patients with three or more pituitary hormone deficiencies and
Search for other papers by Mikkel Andreassen in
Google Scholar
PubMed
Search for other papers by Anders Juul in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Niels Jørgensen in
Google Scholar
PubMed
Liu Z Zhen J Nie M Min L Wu X. Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients . Human Reproduction 2015 30 2031